Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kristensen

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|September 1, 1993
The significance of TFPI in clotting assays--comparison and combination with other anticoagulantsO Nordfang, H I Kristensen, S Valentin, et al.
European Biophysics Journal : EBJ|May 25, 2001
Calcium-dependent association of annexins with lipid bilayers modifies gramicidin A channel parametersK Eskesen, B I Kristensen, A J Jørgensen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 11, 1998
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis modelJ Holst, A T Kristensen, H I Kristensen, et al.
Blood Cells, Molecules & Diseases|March 23, 2011
Cobalt uptake and binding in human red blood cellsLars Ole Simonsen, Anthony M Brown, Henrik Harbak, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Pharmacology of the human red cell voltage-dependent cation channel. Part II: inactivation and blockingPoul Bennekou, Trine L Barksmann, Berit I Kristensen, et al.
Thrombosis and Haemostasis|September 7, 1992
Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparinH I Kristensen, P B Ostergaard, O Nordfang, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|March 25, 2004
Voltage activation and hysteresis of the non-selective voltage-dependent channel in the intact human red cellPoul Bennekou, Trine L Barksmann, Lars R Jensen, et al.
BMC Cancer|February 10, 2023
Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare projectK Sjövall, U Langegård, P Fransson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 2024
To become part of the team-patient experiences of participating in decision-making for a new treatment (proton beam therapy)K Sjövall, K Ahlberg, P Fessé, et al.
Thrombosis Research|October 15, 1991
Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparinH I Kristensen, E M Tromborg, J R Nielsen, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|September 1, 1993
The significance of TFPI in clotting assays--comparison and combination with other anticoagulantsO Nordfang, H I Kristensen, S Valentin, et al.
European Biophysics Journal : EBJ|May 25, 2001
Calcium-dependent association of annexins with lipid bilayers modifies gramicidin A channel parametersK Eskesen, B I Kristensen, A J Jørgensen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 11, 1998
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis modelJ Holst, A T Kristensen, H I Kristensen, et al.
Blood Cells, Molecules & Diseases|March 23, 2011
Cobalt uptake and binding in human red blood cellsLars Ole Simonsen, Anthony M Brown, Henrik Harbak, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Pharmacology of the human red cell voltage-dependent cation channel. Part II: inactivation and blockingPoul Bennekou, Trine L Barksmann, Berit I Kristensen, et al.
Thrombosis and Haemostasis|September 7, 1992
Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparinH I Kristensen, P B Ostergaard, O Nordfang, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|March 25, 2004
Voltage activation and hysteresis of the non-selective voltage-dependent channel in the intact human red cellPoul Bennekou, Trine L Barksmann, Lars R Jensen, et al.
BMC Cancer|February 10, 2023
Evaluating patient reported outcomes and experiences in a novel proton beam clinic - challenges, activities, and outcomes of the ProtonCare projectK Sjövall, U Langegård, P Fransson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 2024
To become part of the team-patient experiences of participating in decision-making for a new treatment (proton beam therapy)K Sjövall, K Ahlberg, P Fessé, et al.
Thrombosis Research|October 15, 1991
Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparinH I Kristensen, E M Tromborg, J R Nielsen, et al.
Pageof 5